-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on CME Group, Raises Price Target to $359

Benzinga·10/22/2026 17:36:43
Listen to the news
Morgan Stanley analyst Michael Cyprys maintains CME Group (NASDAQ:CME) with a Overweight and raises the price target from $337 to $359.